Price Alert

Galectin Therapeutics Inc... (GALT)

NASDAQ: GALT · Real-Time Price · USD

3.57

-0.19 (-5.05%)

At close: Aug 15, 2025, 3:59 PM

3.55

-0.56%

After-hours: Aug 15, 2025, 06:50 PM EDT

Galectin Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	7.43M	15.12M	27.06M	25.6M	23.55M	25.66M	20.36M	17.97M	17.8M	18.59M	15.83M	24.18M	31.61M	39.65M	36.6M	31.6M	20.76M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	243K	243K	306K	333K	385K	437K	490K	612.93K	n/a	733K	793K	n/a	n/a	7K	22K	43K	103K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.85M	2.13M	1.61M	1.69M	1.91M	2.05M	1.25M	1.5M	1.75M	1.96M	1.29M	1.61M	n/a	2.17M	1.4M	1.74M	2.03M
Total Current Assets	9.29M	17.25M	28.67M	27.29M	25.46M	27.71M	21.61M	19.47M	19.55M	20.55M	17.12M	25.79M	33.51M	41.82M	38M	33.33M	22.79M
Property-Plant & Equipment	n/a	n/a	n/a	35K	45K	53K	62K	70.00	673K	n/a	n/a	101K	108K	n/a	18K	28K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	243K	243K	306K	368K	430K	490K	552K	613K	673K	733K	793K	101K	108K	7K	40K	71K	103K
Total Assets	9.53M	17.5M	28.97M	27.66M	25.89M	28.2M	22.16M	20.08M	20.23M	21.29M	17.91M	25.89M	33.62M	41.83M	38.04M	33.41M	22.9M
Account Payables	6.53M	5.66M	2.79M	3.7M	3.8M	6.43M	2.68M	1.98M	2.55M	3.89M	2.35M	2.96M	1.91M	1.8M	1.92M	924K	382K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	97.11M	21.12M	10.52M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	852K	1.89M	1.42M	63K	518K	8.07M	857K	7.29M	386K	8.11M	751K	7.38M	300K	6.49M	520K	4.73M	291K
Total Current Liabilities	110.84M	35.41M	25.26M	14.62M	12.63M	15.68M	10.52M	9.95M	11.53M	13.01M	9.59M	10.89M	9.54M	9.03M	8.3M	6.05M	4.66M
Long-Term Debt	10.81M	85.11M	94.04M	93.42M	82.46M	71.74M	61.14M	60.36M	49.94M	39.83M	29.73M	29.5M	29.27M	29.05M	19.3M	9.64M	n/a
Other Long-Term Liabilities	136K	47K	2.16M	1.76M	1.87M	1M	1.34M	896K	1.34M	639K	850K	626K	998K	1.13M	1.19M	592K	n/a
Total Long-Term Liabilities	10.95M	85.16M	96.19M	95.19M	84.34M	72.77M	62.51M	61.26M	51.34M	40.47M	30.66M	30.22M	30.27M	30.18M	20.49M	10.23M	n/a
Total Liabilities	121.79M	120.56M	121.45M	109.8M	96.98M	88.44M	73.04M	71.21M	62.87M	53.48M	40.25M	41.11M	39.81M	39.21M	28.79M	16.29M	4.66M
Total Debt	107.99M	106.25M	104.59M	93.47M	82.52M	71.81M	61.22M	60.4M	50.04M	39.87M	29.85M	29.62M	29.29M	29.06M	19.32M	9.67M	42K
Common Stock	63K	62K	62K	62K	61K	61K	61K	59K	59K	59K	59K	59K	59K	59K	59K	59K	56K
Retained Earnings	-411.18M	-401.57M	-389.54M	-378.3M	-365.87M	-354.37M	-344.31M	-330.27M	-321.09M	-309.57M	-298.87M	-290.29M	-280.61M	-270.69M	-263.41M	-254.85M	-246.34M
Comprehensive Income	n/a	n/a	n/a	-1.72M	n/a	-61K	n/a	-510K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-112.26M	-103.07M	-92.48M	-82.15M	-71.09M	-60.24M	-50.87M	-51.13M	-42.65M	-32.19M	-22.34M	-15.22M	-6.19M	2.62M	9.25M	17.12M	18.23M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a